Setup, so nobody has to ask: orforglipron · sampling plan.
I have read the primary source rather than the summary, which has left me with more questions.
I understand the headline. I do not understand the footnotes, and the footnotes look important.
What would I need in addition before this supported a decision?
Before anything else, check that the lot number on the certificate matches the vial in your hand — that traces back to your material and not to some other lot from some other date.
Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.
| Test | Answers | Does NOT answer |
|---|---|---|
| RP-HPLC, area % | What fraction of detected material is the target | How much target is present |
| Quantified content | Milligrams of peptide per vial | What the impurities are |
| ESI-MS identity | Whether the molecular weight matches | Purity, or isomeric substitution |
| Peptide mapping | Sequence, localised to a fragment | Quantity |
| Karl Fischer | Water content of the solid | Solvent content |
| LAL endotoxin | Pyrogen load in EU/mg | Sterility |
| Sterility test | Growth in defined media over 14 days | Endotoxin, or bioburden count |
A purity figure to two decimal places with no supporting chromatogram is giving false precision and is a red flag on the same level as spelling errors.
Industry guidance on this topic is consistent because it comes from first principles rather than convention.
One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.
My working rule is that a document without a lot number, a method section and a test date is marketing.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemConcretely, the certificate is only as useful as the lot number, because without traceability it is gossip about someone else's material.
Test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.
Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.
The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.
The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
edited 12 Aug 2026 by s_kalniete — removed a claim I could not source
A certificate without a method section is giving you a claim rather than a measurement, and claims are not evidence.
Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.
The laboratory name and accreditation status can be checked in real time against the testing service's own register, and that two-minute check catches substituted certificates.
Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.
The limitation is cost — truly rigorous testing on every lot is expensive enough that most people do not do it, which is exactly why the variation matters.
If the certificate does not trace to your vial, it is not evidence about your vial.
Specifically, what makes a certificate useful is not its appearance but whether you could hand it to another laboratory and they would reproduce the result.
A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.
My working rule is that a document without a lot number, a method section and a test date is marketing.
More usefully, most certificates are written to look impressive rather than to be informative, and it is worth being sceptical of that gap.
The field you have least reason to trust is the one that looks most impressive, because appearance and accuracy are not correlated.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
edited 6 Aug 2026 by ruaidhri_o_shea — updated for the 2026 guidance change
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.